SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nodality, Inc., which is focused on solving drug development challenges, announced today the launch of its PathPro™ product line. PathPro products leverage the unique capabilities of Nodality’s proprietary Single Cell Network Profiling (SCNP) technology, offering predefined multiparametric flow cytometry-based experimental panels. These panels allow us to study customer inhibitor activity and identify disease subgroups and differential responses in
| < Prev | Next > |
|---|
